CEACAM5 and familial pancreatic carcinoma: This review summarizes well-studied serum protein biomarkers (CA19-9, CEA, mucins, and osteopontin) and explores the potential of emerging biomarkers, including exosomes, circulating tumor cells, microRNAs (miRNAs), circulating tumor DNA (ctDNA), and metabolites in pancreatic cancer detection.